Kromek Group (KMK)

Sector:

Health Care

Index:

FTSE AIM All-Share

6.20p
   
  • Change Today:
      0.50p
  • 52 Week High: 8.00p
  • 52 Week Low: 3.95p
  • Currency: UK Pounds
  • Shares Issued: 641.55m
  • Volume: 4,043,262
  • Market Cap: £39.78m
  • RiskGrade: 527

Kromek awarded two extension contracts worth ?1.6m

By Josh White

Date: Tuesday 24 Sep 2019

LONDON (ShareCast) - (Sharecast News) - Medical, security screening and nuclear detection technology provider Kromek has been awarded two extension contracts relating to its 'D3S' family of products and technologies designed to counter nuclear terrorism, it announced on Tuesday.
The AIM-traded firm said the contracts were worth an aggregate of approximately £1.6m, and would be delivered in the current financial year.

It said the US Government's Countering Weapons of Mass Destruction Office, which is a component within the US Department of Homeland Security, had awarded it a $0.7m (£0.6m) extension contract to add further technical innovation capability to the D3S family of products.

The enhancements would provide greater operational capability by improving user experience, the board explained, and add a specialised reporting function to generate further information for homeland security organisations.

It was also awarded a £1.0m contract extension by a European government-related company, to provide integration of its D3S-related technologies.

The customer was a company that worked with a European government to detect and protect against potential nuclear threats, with the group's solutions set to be used for wide-area threat monitoring.

That brought the total awarded by the customer during the financial year to £2.1m.

"The D3S family of products is gaining increasing momentum globally, with sales in 18 countries, as governments continue to adopt innovative solutions for countering the threat of nuclear terrorism," said chief executive officer Arnab Basu.

"We are also pleased to be receiving further orders from existing customers, which reflects the value that they gain from our solutions. With some of our multi-year trials approaching a successful conclusion, we look forward to additional product and system-level sales of this leading-edge solution in the future."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Kromek Group Market Data

Currency UK Pounds
Share Price 6.20p
Change Today 0.50p
% Change 8.77 %
52 Week High 8.00p
52 Week Low 3.95p
Volume 4,043,262
Shares Issued 641.55m
Market Cap £39.78m
RiskGrade 527

Kromek Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.34% above the market average22.34% above the market average22.34% above the market average22.34% above the market average22.34% above the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average
Price Trend
12.4% below the market average12.4% below the market average12.4% below the market average12.4% below the market average12.4% below the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average
Income Not Available
Growth
26.93% above the market average26.93% above the market average26.93% above the market average26.93% above the market average26.93% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Kromek Group Dividends

No dividends found

Trades for 31-Oct-2024

Time Volume / Share Price
17:07 240,000 @ 6.20p
16:35 90,595 @ 6.20p
16:35 82,595 @ 6.20p
16:35 2,950 @ 6.20p
16:35 5,050 @ 6.20p

Kromek Group Key Personnel

CEO Arnab Basu

Top of Page